Figure 3 also shows that ACVRL1, ENG, SMAD4, SMAD9, and TRPC6 have some mutations in the 5’UTR suggesting that coding mutations are not the only mutations that affect PAH. Here, SMAD9 is linked to pulmonary arterial hypertension.